Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseBone and BonesWhole-Body IrradiationTransplantation, AutologousLeukemiaAnemia, AplasticTransplantation ConditioningTransplantation ChimeraHematopoietic Stem Cell TransplantationTissue DonorsBusulfanGraft SurvivalHematopoietic Stem CellsHistocompatibility TestingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow PurgingRadiation ChimeraHistocompatibilityBone Marrow DiseasesSyndromeRecurrenceMice, Inbred C57BLTransplantation, IsogeneicCyclophosphamideLeukemia, Myeloid, AcuteLeukocyte TransfusionHematopoiesisBone Marrow ExaminationBone RemodelingGraft vs Host ReactionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionLymphocyte DepletionGraft vs Tumor EffectBone Marrow NeoplasmsLiver TransplantationImmunosuppressive AgentsCombined Modality TherapyAcute DiseaseTime FactorsMyelodysplastic SyndromesLeukemia, MyeloidT-LymphocytesTreatment OutcomeImmunosuppressionGraft vs Leukemia EffectHepatic Veno-Occlusive DiseaseChimeraGraft RejectionTransplantation ImmunologyLymphocyte TransfusionBone DensityColony-Forming Units AssayMice, Inbred BALB CSurvival AnalysisCyclosporineNuclear FamilyRetrospective StudiesLymphoma, Non-HodgkinHematologic DiseasesHLA AntigensCytomegalovirus InfectionsKidney TransplantationSpleenBone ResorptionActuarial AnalysisSevere Combined ImmunodeficiencyCell DifferentiationStem Cell TransplantationFlow CytometryPancytopeniaFatal OutcomeGranulocyte Colony-Stimulating FactorLeukocyte CountCells, CulturedSurvival RateAntineoplastic Combined Chemotherapy ProtocolsCytarabineFollow-Up StudiesMultiple MyelomaAntigens, CD34Bone NeoplasmsImmunophenotypingSkin TransplantationLymphomaDisease-Free SurvivalThymus GlandHeart TransplantationMice, KnockoutGranulocytesAntibodies, MonoclonalCell SeparationPrognosisBone DevelopmentAntigens, CD